COMPARISON OF BUSULFAN-BASED AND TREOSULFAN-BASED HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN HIGH-RISK NEUROBLASTOMA

被引：0
|
作者：
Koh, Kyung-Nam [1 ]
Koh, Young Kwon [2 ]
Kang, Aejin [1 ]
Kim, Ji Young [1 ]
Yun, Su Hyun [1 ]
Kang, Sung Han [1 ]
Kim, Hyery [1 ]
Im, Ho Joon [1 ]
机构：
[1] Asan Med Ctr Childrens Hosp, Seoul, South Korea
[2] Chosun Univ, Gwangju, South Korea
来源：
BONE MARROW TRANSPLANTATION | 2024年 / 59卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P675
引用
收藏
页码：610 / 610
页数：1
相关论文
共 50 条
  • [1] COMPARISON OF BUSULFAN-BASED AND TREOSULFAN-BASED CONDITIONING REGIMENS FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH HIGH-RISK NEUROBLASTOMA
    Koh, Young Kwon
    Yoon, Su Hyun
    Kang, Sung Han
    Kim, Hyery
    Im, Ho Joon
    Koh, Kyung-Nam
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S108 - S109
  • [2] Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML
    Gurevich, Ekaterina
    Hayoz, Michael
    Aebi, Yolanda
    Largiader, Carlo R.
    Mansouri Taleghani, Behrouz
    Bacher, Ulrike
    Pabst, Thomas
    CANCERS, 2022, 14 (04)
  • [3] Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
    C Pasqualini
    C Dufour
    G Goma
    M-A Raquin
    V Lapierre
    D Valteau-Couanet
    Bone Marrow Transplantation, 2016, 51 : 227 - 231
  • [4] Phase II Trial of Busulfan-Based Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed By Reduced Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma
    Chen, Yi-Bin
    Li, Shuli
    Del Rio, Candice
    Driscoll, Jessica
    Sadrzadeh, Hossein
    Abramson, Jeremy S.
    Armand, Philippe
    Barnes, Jeffrey
    Cutler, Corey S.
    Fisher, David C.
    Ho, Vincent T.
    Hochberg, Ephraim
    McAfee, Steven L.
    Takvorian, Ronald
    Antin, Joseph H.
    Soiffer, Robert J.
    Jacobsen, Eric
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S73 - S73
  • [5] Treosulfan-based or busulfan-based conditioning for allogeneic transplantation: the role of dose intensity
    Shimoni, Avichai
    LANCET HAEMATOLOGY, 2020, 7 (01): : E4 - E5
  • [6] Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
    Pasqualini, C.
    Dufour, C.
    Goma, G.
    Raquin, M-A
    Lapierre, V.
    Valteau-Couanet, D.
    BONE MARROW TRANSPLANTATION, 2016, 51 (02) : 227 - 231
  • [7] High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma
    Yalcin, Bilgehan
    Kremer, Leontien C. M.
    Caron, Huib N.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08):
  • [8] High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma
    Yalcin, Bilgehan
    Kremer, Leontien C. M.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (10):
  • [9] The Efficacy of High-Dose Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Osteosarcoma
    Sakiyama, Hideki
    Hamada, Satoru
    Yagi, Takeshi
    Miyamoto, Jiro
    Oshiro, Tokiko
    Uehara, Taichi
    Kiyuna, Shinobu
    Tome, Yasunori
    Maehara, Hiroki
    Matsuda, Takehiro
    Higa, Takeshi
    Hyakuna, Nobuyuki
    Nakanishi, Koichi
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S60 - S60
  • [10] High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma
    Yalcin, Bilgehan
    Kremer, Leontien C. M.
    Caron, Huib N.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
12345